Receiptof the decision on granting patent protection for the invention in theterritory of EU.

TheExecutive Board of Genomtec S.A. ("Company", "Issuer") registered inWroclaw, Poland, hereby reports that today The Company has learned abouta positive decision of the European Patent Office granting the Companypatent protection for an invention entitled _quot;ASet for Contactless Temperature Control, a Method of GeneratingElectromagnetic Radiation Wavefronts and the Use of the Set to GenerateProfiles of Temperature Fields _quot;. The EPO has assigned patent No.3735575, and it will be published in the Office's Bulletin on 19February 2025.

Theinvention includes key technical solutions related to the proprietarycontactless heating and temperature detection system, which is used inthe Genomtec ID diagnostic platform. The universality of the approach toobtaining optimal parameters and high heating precision allows thesolution to be used also outside medical applications, e.g. inlithography.

TheIssuer informs that this is the twelfth patent granted to the Company.The Issuer has over thirty patent applications pending worldwide.

TheIssuer's Management Board decided that the receipt of the above patentis confidential information, as in the case of an entity operating onthe molecular diagnostics market, it is necessary to effectively protectintellectual and industrial property. Properly secured intellectual andindustrial property may constitute the Issuer's competitive advantage -and its safe commercialization is possible provided that full protectionis ensured on selected markets.

Inthe opinion of the Management Board, a high level of intellectualproperty protection will also provide the Company with an appropriatenegotiating position before signing commercial agreements with selectedpartners in the scope of implementing the commercialization strategy.